|
1. Biologie
|
|
|
|
|
3.5 Prévention - UV
|
|
|
Indoor tanning rates dropping [Reuters]
|
|
|
|
|
|
We
think the increasing awareness about the dangers of indoor tanning may
be partly responsible for the decrease in indoor tanning,” said lead
author Gery P. Guy Jr., a health economist at the CDC in Atlanta.
|
|
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
More Mammograms May Not Always Mean Fewer Cancer Deaths [NPR]
|
|
|
|
|
|
The
medical community has come to accept that overdiagnosis exists, Elmore
says. "This is something that wasn't even considered when I was in med
school years ago. We're slowly realizing that we are taking healthy
people and maybe potentially giving them harm."
|
|
|
|
|
|
|
|
Breast screening does not reduce cancer deaths, international study warns [The Guardian]
|
|
|
|
|
|
The
latest salvo in the war over breast cancer screening, however,
threatens to reopen the debate. Leading cancer epidemiologists have gone
back to the original trials carried out in Sweden in the 1960s and
1970s. Those trials found that screening could prevent 20-25% of
breast cancer deaths. In a paper in the Journal of the Royal Society of
Medicine, the experts say the methodology of the study was wrong and
that figure is far too high.
|
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
6.1 Observation
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
Making sense of big cancer data [Cancer Research UK]
|
|
|
|
|
|
“Cancers
contain many more mutations than we thought – but finding those that
actually matter is like finding a needle in a haystack,” Dr Dana Pe’er
told the audience at the annual Big Data Analytics Conference held at
the British Library this month.
|
|
|
|
|
|
|
Kevin Fitzpatrick Named CEO of CancerLinQ LLC [ASCO]
|
|
|
|
|
|
Mr.
Fitzpatrick was instrumental in the creation and implementation of the
Diabetes Collaborative Registry™, the first global, cross-specialty
clinical diabetes registry designed to track and improve the quality of
diabetes and metabolic care across the primary care and specialty care
continuum.
|
|
|
|
|
|
|
|
|
6.9 Controverses
|
|
|
|